Junru Liu

880 total citations
79 papers, 555 citations indexed

About

Junru Liu is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Junru Liu has authored 79 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Hematology, 40 papers in Molecular Biology and 36 papers in Oncology. Recurrent topics in Junru Liu's work include Multiple Myeloma Research and Treatments (38 papers), Protein Degradation and Inhibitors (17 papers) and Peptidase Inhibition and Analysis (14 papers). Junru Liu is often cited by papers focused on Multiple Myeloma Research and Treatments (38 papers), Protein Degradation and Inhibitors (17 papers) and Peptidase Inhibition and Analysis (14 papers). Junru Liu collaborates with scholars based in China, Hong Kong and South Korea. Junru Liu's co-authors include Beihui Huang, Juan Li, Juan Li, Zheng Dong, Zhenhai Zhou, Juan Li, Bingqing Zhang, Juan Li, Chang Su and Yan Qu and has published in prestigious journals such as Blood, Biochemical and Biophysical Research Communications and Organic Letters.

In The Last Decade

Junru Liu

68 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junru Liu China 14 227 215 163 93 55 79 555
Michael Bernimoulin Switzerland 13 336 1.5× 156 0.7× 126 0.8× 70 0.8× 74 1.3× 17 714
Patricia Molina Spain 15 211 0.9× 157 0.7× 140 0.9× 125 1.3× 54 1.0× 31 776
Takao Katsube Japan 9 148 0.7× 184 0.9× 105 0.6× 25 0.3× 77 1.4× 17 451
Monica D. Traystman United States 12 191 0.8× 152 0.7× 87 0.5× 68 0.7× 60 1.1× 15 615
Sebastiano Cicco Italy 13 209 0.9× 140 0.7× 188 1.2× 66 0.7× 48 0.9× 52 718
Chi‐Cheng Li Taiwan 13 203 0.9× 137 0.6× 216 1.3× 89 1.0× 61 1.1× 97 698
Dominik Mattern Germany 12 148 0.7× 192 0.9× 149 0.9× 39 0.4× 54 1.0× 22 527
Krizia Pocino Italy 13 116 0.5× 64 0.3× 46 0.3× 109 1.2× 70 1.3× 49 531
Mitsuhiro Iwahashi Japan 12 153 0.7× 238 1.1× 147 0.9× 57 0.6× 43 0.8× 18 914
Manoussos M. Konstadoulakis Greece 15 145 0.6× 53 0.2× 246 1.5× 94 1.0× 106 1.9× 31 539

Countries citing papers authored by Junru Liu

Since Specialization
Citations

This map shows the geographic impact of Junru Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junru Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junru Liu more than expected).

Fields of papers citing papers by Junru Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junru Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junru Liu. The network helps show where Junru Liu may publish in the future.

Co-authorship network of co-authors of Junru Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Junru Liu. A scholar is included among the top collaborators of Junru Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junru Liu. Junru Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Beihui, et al.. (2024). The identification and correction of pseudohypercalcemia. Frontiers in Oncology. 14. 1441851–1441851.
2.
Liu, Junru, et al.. (2024). Case report: Inflammatory bowel disease triggered by secukinumab in a female case of axial spondyloarthritis accompanied with symptomatic epilepsy. International Journal of Rheumatic Diseases. 27(5). e15194–e15194. 1 indexed citations
3.
4.
Liu, Junru, et al.. (2024). Analysis of the Haematological Phenotype and Molecular Characteristics of Rare Abnormal Haemoglobin. Molecular Genetics & Genomic Medicine. 12(9). e70012–e70012. 1 indexed citations
5.
6.
Huang, Beihui, et al.. (2023). RUNX2 promotes the suppression of osteoblast function and enhancement of osteoclast activity by multiple myeloma cells. Medical Oncology. 40(4). 115–115. 3 indexed citations
7.
8.
Zhou, Huixing, Yuan Jian, Juan Du, et al.. (2023). Prognostic nomogram for multiple myeloma early relapse after autologous stem cell transplant in the novel agent era. Cancer Medicine. 12(8). 9085–9096. 2 indexed citations
9.
10.
Tu, Hao-Ran, Junru Liu, Xueqing Zou, et al.. (2022). A deep learning based framework for the classification of multi- class capsule gastroscope image in gastroenterologic diagnosis. Frontiers in Physiology. 13. 1060591–1060591. 4 indexed citations
11.
Qu, Yan, et al.. (2021). Clinical observation and dermoscopy evaluation of fractional CO2 laser combined with topical tranexamic acid in melasma treatments. Journal of Cosmetic Dermatology. 20(4). 1110–1116. 19 indexed citations
12.
13.
Liu, Junru, Swan N. Thung, Ying Li, et al.. (2021). Lymphoepithelioma‐like neoplasm of the biliary tract with ‘probable low malignant potential’. Histopathology. 80(4). 720–728. 11 indexed citations
14.
Gao, Wen, Juan Du, Junru Liu, et al.. (2020). What Multiple Myeloma With t(11;14) Should Be Classified Into in Novel Agent Era: Standard or Intermediate Risk?. Frontiers in Oncology. 10. 538126–538126. 12 indexed citations
15.
Chen, Wen-Ming, Yin Wu, Jianyong Li, et al.. (2019). 1q21 Gain Combined with High-Risk Factors Is a Heterogeneous Prognostic Factor in Newly Diagnosed Multiple Myeloma: A Multicenter Study in China. The Oncologist. 24(11). e1132–e1140. 20 indexed citations
16.
17.
18.
19.
Liu, Junru, He Huang, Yan Li, et al.. (2015). Epidemiology and treatment of invasive fungal diseases in patients with multiple myeloma: findings from a multicenter prospective study from China. Tumor Biology. 37(6). 7893–7900. 9 indexed citations
20.
Huang, Beihui, et al.. (2015). CD20-positive multiple myeloma: can conventional chemotherapy still be used to achieve ideal outcome for these patients?. Leukemia & lymphoma. 57(2). 335–340. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Bernimoulin Breakdown of academic impact, for papers by Patricia Molina Breakdown of academic impact, for papers by Takao Katsube Breakdown of academic impact, for papers by Monica D. Traystman Breakdown of academic impact, for papers by Sebastiano Cicco Breakdown of academic impact, for papers by Chi‐Cheng Li Breakdown of academic impact, for papers by Dominik Mattern Breakdown of academic impact, for papers by Krizia Pocino Breakdown of academic impact, for papers by Mitsuhiro Iwahashi Breakdown of academic impact, for papers by Manoussos M. Konstadoulakis
Rankless by CCL
2026